November 8, 2016
Esperite's revenue slightly lifted in Q3 compared to same period last year
The Ducth pharmaceutical company Esperite N.V. has announced today that cumulative consolidated revenue increased
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Esperite
October 20, 2016
Esperite starts developing inflammatory bowel disease therapies; Starts with Crohn`s disease
Esperite`s business unit The Cell Factory in collaboration with Women`s and Children`s Health Department of the University of Padua and the Padua University Hospital are developing therapies for inflammatory bowel disease (IBD) using extracellular vesicles (EVs).